Additional molecular mediators, including GNG2, a tumor suppressor limiting brain metastasis and FSTL3, which promotes tumor progression via HIF1α-dependent pathways, have emerged as actionable biomarkers for metastatic control (247, 248) (Table 5). The gene discussed is HIF1A; the disease is neoplasm.